Literature DB >> 16035945

Correlation between type of adaptive immune response against porcine circovirus type 2 and level of virus replication.

P Meerts1, S Van Gucht, E Cox, A Vandebosch, H J Nauwynck.   

Abstract

Porcine circovirus 2 (PCV2) replication is characterized by high variation among infected pigs. This study investigated the role of immunologic responses in causing this variation. Twelve gnotobiotic pigs were inoculated with PCV2. Four of these pigs were treated with cyclosporin A (CysA) to monitor the effect of the adaptive immunity on the development of the PCV2 infection. Through lymph node biopsies at 10, 15, and 21 days postinoculation (DPI), PCV2 replication in lymphoid tissues was monitored. The production of total PCV2-specific and PCV2-neutralizing antibodies was followed, together with interferon-gamma (IFN-gamma) mRNA expression levels in peripheral blood monocytes as a marker for cellular immunity. In general, the CysA-treated pigs showed the highest PCV2 titers, indicating that the adaptive immunity is necessary to restrain PCV2 replication. Three different PCV2 replication patterns were observed in non-CysA-treated pigs. Pattern 1: In two pigs, PCV2 was not detected. They had the highest neutralizing antibody titers, appearing from 15 DPI. In these pigs a good cellular response was indicated by a peak in IFN-gamma mRNA at 15 DPI. Pattern 2: Five pigs contained low to moderate PCV2 titers at 15 DPI, remaining constant or decreasing towards 21 DPI. Lower neutralizing antibody titers were observed and no rise in IFN-gamma was detected. Pattern 3: In one pig, a low PCV2 titer at 15 DPI dramatically increased toward 21 DPI. Although an antibody response against PCV2 was mounted, no PCV2-neutralizing antibodies were detected. This pig also showed no rise in IFN-gamma. The study findings indicate that variation in the onset of the adaptive immunity may account for variation in PCV2 replication among pigs. Absence of PCV2-neutralizing antibodies may be an important factor in the development of an increased virus replication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16035945     DOI: 10.1089/vim.2005.18.333

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  22 in total

1.  Unusual outcome of in utero infection and subsequent postnatal super-infection with different PCV2b strains.

Authors:  Dipongkor Saha; Uladzimir U Karniychuk; Liping Huang; Marc Geldhof; Merijn Vanhee; David J Lefebvre; Peter Meerts; Richard Ducatelle; Jan V Doorsselaere; Hans J Nauwynck
Journal:  Virol Sin       Date:  2014-06-17       Impact factor: 4.327

2.  Effect of sow vaccination against porcine circovirus type 2 (PCV2) on virological profiles in herds with or without PCV2 systemic disease.

Authors:  Alfonso Lopez-Rodriguez; Jeroen Dewulf; Tom Meyns; Rubén Del-Pozo-Sacristán; Christine Andreoni; Anne Goubier; Ludivine Chapat; Catherine Charreyre; François Joisel; Dominiek Maes
Journal:  Can Vet J       Date:  2016-06       Impact factor: 1.008

3.  Efficacy of parenteral vaccination against porcine circovirus type 2 (PCV2) in seropositive piglets.

Authors:  Lakshman N A Gamage; Kathleen A McIntosh; Sarah Parker; John Harding; Steven Krakowka; John Ellis
Journal:  Can J Vet Res       Date:  2012-10       Impact factor: 1.310

4.  Development of porcine circovirus 2 (PCV2) open reading frame 2 DNA vaccine with different adjuvants and comparison with commercial PCV2 subunit vaccine in an experimental challenge.

Authors:  Changhoon Park; Jiwoon Jeong; Kyuhyung Choi; Su-Jin Park; Ikjae Kang; Chanhee Chae
Journal:  Can J Vet Res       Date:  2017-07       Impact factor: 1.310

5.  Efficacy comparison of commercial porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae monovalent and bivalent vaccines against a dual challenge.

Authors:  Siyeon Yang; Su-Jin Park; Taehwan Oh; Hyejean Cho; Chanhee Chae
Journal:  Can J Vet Res       Date:  2020-10       Impact factor: 1.310

6.  Co-infection of porcine dendritic cells with porcine circovirus type 2a (PCV2a) and genotype II porcine reproductive and respiratory syndrome virus (PRRSV) induces CD4(+)CD25(+)FoxP3(+) T cells in vitro.

Authors:  T E Cecere; X J Meng; K Pelzer; S M Todd; N M Beach; Y Y Ni; T Leroith
Journal:  Vet Microbiol       Date:  2012-05-08       Impact factor: 3.293

7.  The index herd with PMWS in Sweden: presence of serum amyloid A, circovirus 2 viral load and antibody levels in healthy and PMWS-affected pigs.

Authors:  Per Wallgren; Inger Marit Brunborg; Gunilla Blomqvist; Gunnar Bergström; Frida Wikström; Gordon Allan; Caroline Fossum; Christine Monceyron Jonassen
Journal:  Acta Vet Scand       Date:  2009-03-27       Impact factor: 1.695

8.  Time course differential gene expression in response to porcine circovirus type 2 subclinical infection.

Authors:  Anna Tomás; Lana T Fernandes; Armand Sánchez; Joaquim Segalés
Journal:  Vet Res       Date:  2009-10-14       Impact factor: 3.683

9.  Porcine circovirus type 2 (PCV2)-infection and re-inoculation with homologous or heterologous strains: virological, serological, pathological and clinical effects in growing pigs.

Authors:  Tanja Opriessnig; John R Prickett; Darin M Madson; Hui-Gang Shen; Nicole M Juhan; Roman R Pogranichniy; Xiang-Jin Meng; Patrick G Halbur
Journal:  Vet Res       Date:  2010-01-18       Impact factor: 3.683

10.  Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge.

Authors:  Hwi Won Seo; Yeonsu Oh; Kiwon Han; Changhoon Park; Chanhee Chae
Journal:  BMC Vet Res       Date:  2012-10-19       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.